Hyalo Technologies is a biotechnology and pharmaceutical company based in Somerset, New Jersey that develops next-generation drug-delivery platforms using nanotechnology. Its proprietary delivery systems are designed to improve the efficacy and safety of active ingredients by enabling targeted, time-controlled and biodegradable release. The company collaborates with pharmaceutical, cosmetic and nutraceutical partners to create transdermal and topical formulations. Hyalo Technologies operates R&D laboratories and corporate offices in New Jersey and offers custom formulation, technology licensing and co-development. Its mission is to revolutionize drug delivery by leveraging nanotechnology to enhance therapeutic effect while maintaining user safety. Products include hyaluronic-acid-based carriers and encapsulation systems for active ingredients and peptides.